Screening tools for clinical high risk for psychosis

Early Intervention in Psychiatry

Volumn 9, Issue 5, 2015, Pages 345-356

  Addington, Jean ^a   Stowkowy, Jacqueline ^a   Weiser, Mark ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

At risk mental state; Clinical high risk; Prodrome; Psychosis; Screening

Indexed keywords

ADOLESCENT PSYCHOTIC LIKE SYMPTOM SCREENER; CLINICAL ASSESSMENT TOOL; COMMUNITY ASSESSMENT OF PSYCHIC EXPERIENCE 42; COMMUNITY ASSESSMENT OF PSYCHIC EXPERIENCE P; COMMUNITY ASSESSMENT OF PSYCHIC EXPERIENCE P15; COMPOSITE PSYCHOSIS RISK QUESTIONNAIRE; EARLY DETECTION PRIMARY CARE CHECKLIST; EPPENDORF SCHIZOPHRENIA INVENTORY; HIGH RISK PATIENT; HUMAN; INTERVIEW FOR PSYCHOSIS LIKE SYMPTOM; PREDICTIVE VALUE; PRIMARY CARE CHECKLIST; PRIME SCREEN; PRIME SCREEN REVISED; PRIORITY JOURNAL; PRODROMAL QUESTIONNAIRE; PRODROMAL SYMPTOM; PSYCHOSIS; QUESTIONNAIRE; REVIEW; SELF SCREEN PRODROME; SENSITIVITY AND SPECIFICITY; SPRO PSY RISK; YOUTH PSYCHOSIS AT RISK QUESTIONNAIRE; YOUTH PSYCHOSIS AT RISK QUESTIONNAIRE BRIEF; YOUTH PSYCHOSIS AT RISK QUESTIONNAIRE BRIEF VERSION; EARLY DIAGNOSIS; PSYCHOLOGICAL RATING SCALE; PSYCHOTIC DISORDERS;

EARLY DIAGNOSIS; HUMANS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS;

EID: 84940891616     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/eip.12193     Document Type: Review

References (61)

1. Addington J. The promise of early intervention. Early Interv Psychiatry 2007; 1: 294-307.
2. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 2009; 39: 179-195.
3. Fusar-Poli P, Bonoldi I, Yung AR etal. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 2012; 69: 220-229.
4. Yung AR, Yuen HP, McGorry PD etal. Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 2005; 39: 964-971.
5. McGlashan T, Walsh BC, Woods SW. The Psychosis Risk Syndrome: Handbook for Diagnosis and Follow-up. New York: Oxford University Press, 2010.
6. Jablensky A. Research methods in psychiatric epidemiology: an overview. Aust N Z J Psychiatry 2002; 36: 297-310.
7. Olsen KA, Rosenbaum B. Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiatr Scand 2006; 113: 247-272.
8. Eaton WW, Romanoski A, Anthony JC, Nestadt G. Screening for psychosis in the general population with a self-report interview. J Nerv Ment Dis 1991; 179: 689-693.
9. Stefanis NC, Hanssen M, Smirnis NK etal. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol Med 2002; 32: 347-358.
10. Peters E, Joseph S, Day S, Garety P. Measuring delusional ideation: the 21-item Peters etal. Delusions Inventory (PDI). Schizophr Bull 2004; 30: 1005-1022.
11. Konings M, Bak M, Hanssen M, van Os J, Krabbendam L. Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population. Acta Psychiatr Scand 2006; 114: 55-61.
12. Mossenheb N, Becker J, Schaefer MR, Klier CM, Schloegelhofer M, Papageorgiou K etal. The community assessment of psychic experiences (CAPE) questionnaire as a screening instrument in the detection of individuals at ultra-high risk for psychosis. Schizophr Res 2012; 141: 210-214.
13. Capra C, Kavanagh DJ, Hides L, Scott J. Brief screening for psychosis-like experiences. Schizophr Res 2013; 149: 104-107.
14. Heinimaa M, Salokangas RK, Ristkari T etal. PROD-screen - a screen for prodromal symptoms of psychosis. Int J Methods Psychiatr Res 2003; 12: 92-104.
15. Miller TJ, Cicchetti D, Markovich PJ, Woods SW. The SIPS Screen: a brief self-report screen to detect the schizophrenia prodrome. Schizophr Res 2004; 70: 78.
16. Kobayashi H, Nemoto T, Koshikawa H etal. A self-reported instrument for prodromal symptoms of psychosis: testing the clinical validity of the PRIME Screen-Revised (PS-R) in a Japanese population. Schizophr Res 2008; 106: 356-362.
17. Kobayashi H, Yamazawa R, Nemoto T, Murakami M, Kashima H, Mizuno M. Correlation between attenuated psychotic experiences and depressive symptoms among Japanese students. Early Interv Psychiatry 2010; 4: 200-205.
18. Kobayashi H, Nemoto T, Murakami M, Kashima H, Mizuno M. Lack of association between psychosis-like experiences and seeking help from professionals: a case-controlled study. Schizophr Res 2011 Nov; 132: 208-212.
19. Kline E, Wilson C, Ereshefsky S etal. Psychosis risk screening in youth: a validation study of three self-report measures of attenuated psychosis symptoms. Schizophr Res 2012; 141: 72-77.
20. Kline E, Thompson E, Schimunek C etal. Parent-adolescent agreement on psychosis risk symptoms. Schizophr Res 2013; 147: 147-152.
21. Ord LM, Myles-Worsley M, Blailes F, Ngiralmau H. Screening for prodromal adolescents in an isolated high-risk population. Schizophr Res 2004; 71: 507-508.
22. Loewy RL, Bearden CE, Johnson JK, Raine A, Cannon TD. The prodromal questionnaire (PQ): preliminary validation of a self-report screening measure for prodromal and psychotic syndromes. Schizophr Res 2005; 79: 117-125.
23. Loewy RL, Therman S, Manninen M, Huttunen MO, Cannon TD. Prodromal psychosis screening in adolescents. Early Interv Psychiatry 2012; 6: 69-75.
24. Rietdijk J, Klaassen R, Ising H etal. Detection of people at risk of developing a first psychosis: comparison of two recruitment strategies. Acta Psychiatr Scand 2012; 126: 21-30.
25. Loewy RL, Stuart B, Schlosser D, Vinogradov S, Cannon TD. Prodromal psychosis screening with the Prodromal Questionnaire-Brief version (PQ-B). Early Interv Psychiatry 2008; 2: A40.
26. Loewy RL, Pearson R, Vinogradov S, Bearden CE, Cannon TD. Psychosis risk screening with the Prodromal Questionnaire - brief version (PB-Q). Schizophr Res 2011; 129: 42-46.
27. Jarrett M, Craig T, Parrott J etal. Identifying men at ultra high risk of psychosis in a prison population. Schizophr Res 2012; 136: 1-6.
28. Ising HK, Veling W, Loewy RL etal. The validity of the 16-item version of the Prodromal Questionnaire (PQ-16) to screen for ultra high risk of developing psychosis in the general help-seeking population. Schizophr Bull 2012; 38: 1288-1296.
29. Horwood J, Salvi G, Thomas K etal. IQ and non-clinical psychotic symptoms in 12-year-olds: results from the ALSPAC birth cohort. Br J Psychiatry 2008; 193: 185-191.
30. Kelleher I, Harley M, Murtagh A, Cannon M. Are screening instruments valid for psychotic-like experiences? A validation study of screening questions for psychotic-like experiences using in-depth clinical interview. Schizophr Bull 2009; 37: 362-369.
31. Niessen MA, Dingemans PM, van de Fliert R, Becker HE, Nieman DH, Linszen D. Diagnostic validity of the Eppendorf Schizophrenia Inventory (ESI): a self-report screen for ultrahigh risk and acute psychosis. Psychol Assess 2010; 22: 935-944.
32. Chung Y, Kang NI, Im YJ etal. Validation of the Korean version of the Eppendorf Schizophrenia Inventory as a screening measure to detect adolescents at ultra-high risk for psychosis. Early Interv Psychiatry 2013; 7: 71-79.
33. Kammermann J, Stieglitz RD, Riecher-Rossler A. ['Self-screen prodrome' - self-rating for the early detection of mental disorders and psychoses]. Fortschr Neurol Psychiatr 2009; 77: 278-284.
34. Mueller M, Riecher A, Kammermann J, Stieglitz RD, Stettbacher A, Vetter S. Prediction of caseness for mental pathology in Swiss conscripts: the Self-Screen Prodrome. Mil Med 2009; 174: 1270-1275.
35. Muller M, Vetter S, Buchli-Kammermann J, Stieglitz RD, Stettbacher A, Riecher-Rossler A. The Self-screen-Prodrome as a short screening tool for pre-psychotic states. Schizophr Res 2010; 123: 217-224.
36. French P, Owens J, Parker S, Dunn G. Identification of young people in the early stages of psychosis: validation of a checklist for use in primary care. Psychiatry Res 2012; 200: 911-916.
37. Liu CC, Tien YJ, Chen CH etal. Development of a brief self-report questionnaire for screening putative pre-psychotic states. Schizophr Res 2013; 143: 32-37.
38. Peters ER, Garety PA. The Peters etal. Delusions inventory (PDI): new norms for the 21-item version. Schizophr Res 1996; 18: 118-119.
39. Hanssen M, Peeters F, Krabbendam L, Radstake S, Verdoux H, van Os J. How psychotic are individuals with non-psychotic disorders? Soc Psychiatry Psychiatr Epidemiol 2003; 38: 149-154.
40. Welham J, Scott J, Williams G etal. Emotional and behavioural antecedents of young adults who screen positive for non-affective psychosis: a 21-year birth cohort study. Psychol Med 2009; 39: 625-634.
41. Brenner K, Schmitz N, Pawliuk N etal. Validation of the English and French versions of the Community Assessment of Psychic Experiences (CAPE) with a Montreal community sample. Schizophr Res 2007; 95: 86-95.
42. Stefanis NC, Delespaul P, Henquet C, Bakoula C, Stefanis CN, van OS J. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004; 99: 1333-1341.
43. Hafner H, Riecher-Rossler A, Hambrecht M etal. IRAOS: an instrument for the Assessment of onset and early course of schizophrenia. Schizophr Res 1992; 6: 209-223.
44. Gross G, Huber G. Basic symptoms and prodromal phase of schizophrenia. Neurol Psychiatry Brain Res 2005; 12: 185-198.
45. Grano N, Karjalainen M, Itkonen A etal. Differential results between self-report and interview-based ratings of risk symptoms of psychosis. Early Interv Psychiatry 2011; 5: 309-314.
46. Miller TJ, McGlashan TH, Rosen JL etal. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 2003; 29: 703-715.
47. Myles-Worsley M, Blailes F, Ord LM, Weaver S, Dever G, Faraone SV. The Palau Early Psychosis Study: distribution of cases by level of genetic risk. Am J Med Genet B Neuropsychiatr Genet 2007; 144B: 5-9.
48. Chambers WJ, Puig-Antich J, Hirsch M etal. The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version. Arch Gen Psychiatry 1985; 42: 696-702.
49. Raine A. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull 1991; 17: 555-564.
50. Schreier A, Wolke D, Thomas K etal. Prospective study of peer victimization in childhood and psychotic symptoms in a nonclinical population at age 12 years. Arch Gen Psychiatry 2009; 66: 527-536.
51. Zammit S, Horwood J, Thompson A etal. Investigating if psychosis-like symptoms (PLIKS) are associated with family history of schizophrenia or paternal age in the ALSPAC birth cohort. Schizophr Res 2008; 104: 279-286.
52. World Health Organization (WHO). Schedules for Clinical Assessment in Neuropsychiatry American Psychiatric Research. Geneva: World Health Organization, 1994.
53. Golding J, Pembrey M, Jones R. ALSPAC - the Avon Longitudinal Study of Parents and Children. I. Study methodology. Paediatr Perinat Epidemiol 2001; 15: 74-87.
54. Wing JK, Birley JL, Cooper JE, Graham P, Isaacs AD. Reliability of a procedure for measuring and classifying 'present psychiatric state'. Br J Psychiatry 1967; 113: 499-515.
55. Kaufman J, Birmaher B, Brent D etal. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 1997; 36: 980-988.
56. Mass R, Haasen C, Wolf K. [The Eppendorf Schizophrenia Inventory (ESI). Development and evaluation of a questionnaire for assessment of characteristic self perception of cognitive dysfunctions by schizophrenic patients]. Nervenarzt 2000; 71: 885-892.
57. Klosterkotter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58: 158-164.
58. Mass R, Schoemig T, Hitschfeld K, Wall E, Haasen C. Psychopathological syndromes of schizophrenia: evaluation of the dimensional structure of the Positive and Negative Syndrome Scale. Schizophr Bull 2000; 26: 167-177.
59. Chapman LJ, Chapman JP, Kwapil TR, Eckblad M, Zinser MC. Putatively psychosis-prone subjects 10 years later. J Abnorm Psychol 1994; 103: 171-183.
60. Nakayasu N, Seki Y, Harima H. Age of onset, frequency of the development of symptoms, and treatment outcome in the early stage of schizophrenia-in search of guidelines for early diagnosis and treatment of schizophrenia. Seishin Shinkeigaku Zasshi 1999; 101: 898-907.
61. Gale C, Glue P, Gallagher S. Bayesian analysis of posttest predictive value of screening instruments for the psychosis high-risk state. JAMA Psychiatry 2013; 70: 880-881.